How to Replace OB/GYN Referrals During a Shutdown

coronavirus business response webinar - 4/28/20 4PM EDT

griffin@grifjones.com

60% of a fertility center's patients are referred by a physician.

Not anymore...at least not for the moment.

What happens when a global pandemic stops almost everyone from visiting their PCP or OB/GYN for two months or perhaps, much longer? The good news is that you don't have to worry about disrupting local referral patterns anymore. They've been disrupted for you.

After a potential spike in fertility treatments once semi-normal operations resume, what do we do when a much smaller percentage of patients are able to move forward with treatment?

In this live "Ask Me Anything" (AMA), we'll focus on the top phase of the Fertility Marketing Funnel so that you can start filling it now, mitigating a potentially massive drop in new patient volumes and IVF cycles in 3-6 months. If we don't increase our reach of potential patients, the risk to our employees' livelihoods will be greater and longer than a temporary furlough.

I'm going to keep this one short, 20-30 minutes, so be on time and ready to take notes

 

About the host

Griffin Jones is Fertility Bridge’s founder and voice behind the Inside Reproductive Health podcast. He has built a full-service marketing firm for fertility centers from the ground up and drives the company’s direction with his strategic initiative. His direct involvement with the reproductive health field has given Fertility Bridge the ability to bring value to the REI community through dynamic, meaningful content. Griffin works hard to foster growth within his employees because he truly believes a company is only as good as the values they work and live by. If you want to impress him, talk Big Brothers Big Sisters, Nuestros Pequeños Hermanos, and the city of Buffalo, his three biggest passions outside of work and family.

Griffin Jones is the founder and Director of Business Development at Fertility Bridge.

Griffin Jones is the founder and Director of Business Development at Fertility Bridge.